Risk factors for relapse and post-relapse outcomes in patients with Philadelphia chromosome-negative B-cell acute lymphoblastic leukemia receiving frontline blinatumomab-based regimens
Year: 2025
Type: conference-abstract
Source: Blood
Authors: Sankalp Arora, Koji Sasaki, Nicholas Short, Nitin Jain, Farhad Ravandi, Fadi Haddad, Jayastu Senapati, Guillermo Montalban-Bravo, Alexandre Bazinet, Rita Khouri, Rebecca Garris, Hagop Kantarjian, Elias Jabbour
Institution: The University of Texas MD Anderson Cancer Center
Language: English
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4417001849